Shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report) passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $6.15 and traded as low as $1.26. ZIVO Bioscience shares last traded at $1.41, with a volume of 8,094 shares.
ZIVO Bioscience Stock Performance
The firm has a fifty day moving average price of $6.15 and a 200 day moving average price of $11.45.
Institutional Trading of ZIVO Bioscience
A hedge fund recently raised its stake in ZIVO Bioscience stock. Vanguard Group Inc. boosted its position in ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Free Report) by 19.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 92,468 shares of the biotechnology company’s stock after acquiring an additional 15,147 shares during the period. Vanguard Group Inc. owned 0.98% of ZIVO Bioscience worth $359,000 at the end of the most recent quarter. Institutional investors and hedge funds own 14.12% of the company’s stock.
ZIVO Bioscience Company Profile
ZIVO Bioscience, Inc, a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.
- Five stocks we like better than ZIVO Bioscience
- Roth IRA Calculator: Calculate Your Potential Returns
- Catch the dip on Sociedad Quimica before earnings?
- Market Cap Calculator: How to Calculate Market Cap
- Can new GPT store spur generative AI monetization?
- How to Analyze Restaurant Stocks
- Energy looks to dominate markets with 3 oil and gas stocks
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.